5-year survey of methotrexate, cyclophosphamide (Endoxan), and vincristine (MEV) therapy for advanced non-Hodgkin's lymphomas

F. Lauria, M. Baccarani, M. Fiacchini, R. Frezza, M. Gobbi, S. Tura

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of '5-year survey of methotrexate, cyclophosphamide (Endoxan), and vincristine (MEV) therapy for advanced non-Hodgkin's lymphomas'. Together they form a unique fingerprint.

Medicine & Life Sciences